Keratan sulfate in body fluids in joint disease

被引:14
作者
Thonar, EJM
Masuda, K
Hauselmann, HJ
Uebelhart, D
Lenz, ME
Manicourt, DH
机构
[1] RUSH PRESBYTERIAN ST LUKES MED CTR,RUSH MED COLL,DEPT INTERNAL MED,CHICAGO,IL 60612
[2] UNIV SPITAL ZURICH,RHEUMAKLIN,ZURICH,SWITZERLAND
[3] UNIV SPITAL ZURICH,INST PHYS THERAPIE,ZURICH,SWITZERLAND
[4] UNIV BERN,ME MULLER INST BIOMECH,BERN,SWITZERLAND
[5] UNIV GENEVA,HOP CANTONAL,DEPT MED PHYS & REEDUC,DIV MED PHYS & REEDUC,CH-1211 GENEVA,SWITZERLAND
[6] UNIV CATHOLIQUE LOUVAIN,SERV RHUMATOL,B-1200 BRUSSELS,BELGIUM
来源
ACTA ORTHOPAEDICA SCANDINAVICA | 1995年 / 66卷
关键词
D O I
10.3109/17453679509157662
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Keratan sulfate (KS) is a highly-negatively charged glycosaminoglycan which is found principally in aggrecan, the most abundant proteoglycan in the extracellular matrix of hyaline, fibrous and elastic cartilage. In 1985, we discovered that small peptidoglycans bearing antigenic KS (agKS) were present in small amounts in human serum and postulated that the great majority of these were derived from the degradation of cartilage aggrecan (Thonar et al. 1985). During the past decade, studies of antigenic KS in joint fluid and serum have provided strong evidence in support of this hypothesis. By asking questions which could not have been addressed previously, these studies have shed new light upon the metabolism of aggrecan in vivo. In this manuscript, we describe some of these findings and put in perspective their contribution to our understanding of the metabolism of aggrecan in joint diseases. © 1995 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 19 条
[1]
LEVELS OF KERATAN SULFATE IN THE SERUM AND SYNOVIAL-FLUID OF PATIENTS WITH OSTEOARTHRITIS OF THE KNEE [J].
CAMPION, GV ;
MCCRAE, F ;
SCHNITZER, TJ ;
LENZ, ME ;
DIEPPE, PA ;
THONAR, EJMA .
ARTHRITIS AND RHEUMATISM, 1991, 34 (10) :1254-1259
[2]
DINGLE JT, 1991, J RHEUMATOL, V18, P30
[3]
FUKUDA K, 1993, ORTHOP T, V18, P217
[4]
LOHMANDER LS, 1993, J RHEUMATOL, V20, P1362
[5]
LEVELS OF CIRCULATING TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RELATIONSHIP TO SERUM LEVELS OF HYALURONAN AND ANTIGENIC KERATAN SULFATE [J].
MANICOURT, DH ;
TRIKI, R ;
FUKUDA, K ;
DEVOGELAER, JP ;
DEDEUXCHAISNES, CN ;
THONAR, EJMA .
ARTHRITIS AND RHEUMATISM, 1993, 36 (04) :490-499
[6]
MANICOURT DH, 1991, J RHEUMATOL, V18, P1872
[7]
MANICOURT DH, IN PRESS J RHEUMATOL
[8]
SERUM KERATAN SULFATE - QUANTITATIVE AND QUALITATIVE COMPARISONS IN INFLAMMATORY VERSUS NONINFLAMMATORY ARTHRITIDES [J].
MEHRABAN, F ;
FINEGAN, CK ;
MOSKOWITZ, RW .
ARTHRITIS AND RHEUMATISM, 1991, 34 (04) :383-392
[9]
MOK SS, 1994, J BIOL CHEM, V269, P33021
[10]
PACHMAN LM, 1987, ARTHRITIS RHEUM, V30, pS20